SMTL ID : 2c6m.1

Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x DT5: 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE(Non-covalent)

DT5.1: 16 residues within 4Å: Chain A: I.10, G.11, E.12, V.18, A.31, K.33, V.64, E.81, F.82, L.83, H.84, Q.85, D.86, K.89, Q.131, L.134 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.10, A:V.18, A:D.86, A:L.134 Hydrogen bonds: A:K.33, A:L.83, A:L.83, A:H.84, A:D.86, A:K.89 Water bridges: A:Q.85

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Richardson, C.M. et al., Triazolo[1,5-A]Pyrimidines as Novel Cdk2 Inhibitors: Protein Structure-Guided Design and Sar. Bioorg.Med.Chem.Lett. (2006)

Release Date

2005-12-07

Peptides

CELL DIVISION PROTEIN KINASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CELL DIVISION PROTEIN KINASE 2

Related Entries With Identical Sequence